APPLY

There are discoveries that change health today.
And there are discoveries that transform the health of tomorrow.

Welcome to the Pharma Revolution

Compete for the €100,000 Jorge Ruas Award and take your Pharmaceutical Technology innovation further.

100k€

The winning project will receive €100,000 in prize money.

Advancing breakthrough Pharmaceutical Technology

The Tecnimede Open Innovation Competition connects Tecnimede Group with research groups, startups, companies and innovators developing breakthrough solutions in Pharmaceutical Technology with the potential to improve patient care and deliver meaningful impact for patients and healthcare systems.

ABOUT THE COMPETITION

What we are looking for

We are looking for projects with the potential to advance Pharmaceutical Technology and address meaningful healthcare needs. Projects may include:

· Drug Repurposing
· Drug Discovery
· Manufacturing Processes
· Digital Health
· Personalised Medicine
· Artificial Intelligence and Machine Learning Applications
· Nanotechnology
· Other emerging areas in Pharmaceutical Technology

Eligible projects must be at TRL 3-7.

APPLICATIONS

24 November 2026 - 12 March 2027

Applications to the Tecnimede Open Innovation Competition 2027 must be submitted online, in English, through the Competition website.

A complete application includes:

  • Online application form
  • Project roadmap presented as a Gantt chart
  • Project presentation- maximum 12 slides
  • Motivation and collaboration letter
  • Project video- maximum 5 minutes

The application period may close earlier if the maximum limit of 100 valid applications is reached.

How the Competition Works

From application submission to the Final Event, projects progress through a structured evaluation and selection process.

0.
Application Submission

Submit your complete application online within the application period.

1.
Screening

Applications are screened to confirm compliance with the eligibility requirements.

2.
Selection

Eligible applications are evaluated and shortlisted for remote interviews. Following the interviews, up to 10 finalists are selected to progress to the Final Event.

3.
Final Event

Finalists present their projects before the Judging Panel, which evaluates the projects and selects the winner of the Jorge Ruas Award.

NEXT EVENT

Information Session

December 3rd

14:30 GMT

Learn about the Tecnimede Open Innovation Competition 2027, eligibility, evaluation process and how to prepare your application.

Online

THE JORGE RUAS AWARD

Honouring a legacy of innovation

A visionary pulmonologist, entrepreneur and one of the founders of Tecnimede Group, Jorge Ruas da Silva dedicated his career to advancing science, healthcare and pharmaceutical innovation.

The Jorge Ruas Award honours his legacy by recognising groundbreaking innovation in Pharmaceutical Technology and encouraging future generations to pursue excellence and human-centred innovation.

THE JURY

2027 Jury

The Tecnimede Open Innovation Competition brings together experts from the pharmaceutical, scientific, business and innovation communities to evaluate the participating projects throughout the Competition.

Watch the highlights from the Tecnimede Open Innovation Competition 2026 Final

On 27 May, researchers, entrepreneurs, investors, healthcare professionals, and pharmaceutical industry leaders gathered to celebrate innovation in pharmaceutical technologies.

THE FINALISTS

2026 Finalists

The Tecnimede Open Innovation Competition has reached its final stage, with 10 finalist teams selected to compete for the Jorge Ruas Award at the Final Event, taking place on 27 May, from 14:00 to 18:10, at Pavilhão do Conhecimento, in Lisbon (Portugal).